Detection of anticoagulants with rotational thromboelastometry (ROTEM).

Detection of anticoagulants with rotational thromboelastometry (ROTEM). - DOAR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015704

Enrollment

Registered

2018-10-05

Start date

2018-11-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D68

Interventions

Group 1: The new oral anticoagulants dabigatran, edoxaban, apixaban and rivaroxaban as well as marcumar are to be investigated by means of rotational thrombelastometry (ROTEM). For this purpose, new t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years. Intake of anticoagulation. Approval of the patient.

Exclusion criteria

Exclusion criteria: Age < 18 years. Intake of other anticoagulants. Known coagulation disorder. Rejection of the patient.

Design outcomes

Primary

Measure	Time frame
Modification of the specific tests Ecatem® and TFtem® compared to blood samples without anticoagulant.	—

Secondary

Measure	Time frame
Change of the known tests EXTEM and INTEM compared to blood samples without anticoagulant.	—

Countries

Germany

Contacts

Public ContactSimon Schäfer

Klinik für Anästhesiologie, Klinikum der Universität München, LMU München

simon.schaefer@med.uni-muenchen.de089440081142

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 21, 2026